Seelos Therapeutics, Inc. (SEELQ) — Financial Flexibility Index
Seelos Therapeutics, Inc. (SEELQ) has a Financial Flexibility Index of -0.03x as of June 2024. Free cash flow of $-972.00K (operating CF $-972.00K minus capex $0.00) represents 0% of total liabilities ($30.51 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Seelos Therapeutics, Inc. Financial Flexibility Index (2020–2023)
Historical Financial Flexibility Index trend for Seelos Therapeutics, Inc. across 4 annual periods. See Seelos Therapeutics, Inc. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Seelos Therapeutics, Inc. (2020–2023)
Year-by-year free cash flow to debt coverage for Seelos Therapeutics, Inc.. For the full company profile including market capitalisation, see Seelos Therapeutics, Inc. (SEELQ) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.61x | $-23.91 Million | $-23.91 Million | $38.93 Million | ▲ +66.7% |
| 2022 | -1.85x | $-61.60 Million | $-61.60 Million | $33.36 Million | ▲ +1.3% |
| 2021 | -1.87x | $-48.99 Million | $-48.99 Million | $26.18 Million | ▼ -33.5% |
| 2020 | -1.40x | $-20.91 Million | $-20.91 Million | $14.92 Million | — |